Cancer Today Staff

Why Is Liver Cancer on the Rise?

Although liver cancer isn’t as prevalent as lung cancer or breast cancer, this cancer is now the fastest-increasing cause of cancer death in the United States. In the Spring 2018 issue of Cancer Today, contributing editor Sue Rochman explored contributing factors for the increased liver cancer incidence since the mid-1970s.

Read More

Advice from Advocates: How to Navigate the Annual Meeting

Two graduates of the AACR Scientist↔Survivor Program, a special educational experience that gives patient advocates the opportunity to attend and learn from researchers at the AACR Annual Meeting, have put together some tips to help guide advocates who are attending this or any large scientific conference.

Read More

DNA Profiling Moves From Forensics to Diagnostics

Television series like CSI: Crime Scene Investigation familiarized viewers with advances in forensic science that allow investigators to detect minute amounts of a person’s unique DNA sequence found at a crime scene and analyze it to implicate or exonerate a suspect. Similar DNA technologies can also detect and analyze small numbers of cancer cells in blood.

Read More

The Vital Role of Caregivers

Before her husband, Tony, was diagnosed with stomach cancer in 2012, Christy Leonard knew little about caregiving. Leonard, who works in information technology, soon found herself giving injections and operating a feeding tube, all while working from home and caring for the couple’s children. Meanwhile, “I did absolutely nothing for myself,” she said.

Read More

Team Science: A Winning Approach to Research

In 1993, Jon R. Katzenbach and Douglas K. Smith authored The Wisdom of Teams, a collection of observations and insights into how high-performance teams can be assembled and managed. Many of the principles elaborated in the book are applicable to team science for cancer research.

Read More

Can Molecular Analysis be Tapped to Tackle Brain Cancer?

Compared to treatment advances for other types of cancer, progress in treating brain cancer has been frustratingly slow. Still, understanding the molecular changes that drive brain cancer remains “potentially transformative,” says Paul Mischel, a cancer biologist and neuropathologist at the Ludwig Institute for Cancer Research in San Diego.

Read More

Broadening Clinical Trial Participation

Patient enrollment in clinical trials has long been on the minds of oncologists and researchers. In 1990, fewer than 3 percent of patients were enrolled in clinical trials—which spurred then president-elect of the American Cancer Society, Walter Lawrence Jr., MD, to write an editorial calling for more concerted efforts. More than 25 years later, clinical trial participation hovers around 5 percent.

Read More